Cargando…
Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform—A Cardiac Perspective
A comprehensive understanding of the pathophysiology and cellular responses to drugs in human heart disease is limited by species differences between humans and experimental animals. In addition, isolation of human cardiomyocytes (CMs) is complicated because cells obtained by biopsy do not prolifera...
Autores principales: | Bekhite, Mohamed M., Schulze, P. Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699880/ https://www.ncbi.nlm.nih.gov/pubmed/34943991 http://dx.doi.org/10.3390/cells10123483 |
Ejemplares similares
-
Human induced pluripotent stem cell-based platform for modeling cardiac ischemia
por: Häkli, Martta, et al.
Publicado: (2021) -
Human Induced Pluripotent Stem Cells as a Screening Platform for Drug-Induced Vascular Toxicity
por: Tu, Chengyi, et al.
Publicado: (2021) -
Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery
por: Jang, Jiho, et al.
Publicado: (2012) -
Miniaturized droplet microarray platform enables maintenance of human induced pluripotent stem cell pluripotency
por: Liu, Yanxi, et al.
Publicado: (2021) -
Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform
por: Lodrini, Alessandra Maria, et al.
Publicado: (2020)